Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 218
Filtrar
1.
BMC Oral Health ; 22(1): 643, 2022 12 26.
Artículo en Inglés | MEDLINE | ID: mdl-36567353

RESUMEN

Dental pulp and periapical diseases are common conditions in stomatology, caused by various pathogenic microorganisms. Antimicrobial peptides, as new antibiotics, offer promising applications in the irrigation and disinfection medicaments for root canals.One patient with chronic periapical periodontitis was selected to extract the clinical pathogenic bacteria. Porphyromonas gingivalis (Pg) (ATCC 33,277), Streptococcus mutans (Sm) (ATCC 25,175), and Prevotella intermedius (Pi) (ATCC 25,611) were used as test strains. The effects of plantaricin (Pln) 149 on the biofilm formation and growth in infected root canals were evaluated by RT-PCR, laser confocal scanning microscopy, and bacterial diversity analysis. In addition, the cytotoxicity of Pln 149 (100 µg/mL) to human dental pulp stem cells (hDPSCs) was assessed using an MTT assay. Pln 149 exhibited significant inhibitory effects on Pg Sm and Pi (P < 0.05), with significant differences in the biofilm images of the laser confocal scanning microscope (P < 0.05). There were no significant differences in hDPSCs viability or proliferation between the Pln 149 and control groups. Considering the excellent antimicrobial effects and low cytotoxicity, we suggest that Pln 149 might be a promising option for root canal irrigation solutions.


Asunto(s)
Antibacterianos , Bacteriocinas , Cavidad Pulpar , Irrigantes del Conducto Radicular , Preparación del Conducto Radicular , Humanos , Antibacterianos/farmacología , Cavidad Pulpar/microbiología , Irrigantes del Conducto Radicular/química , Irrigantes del Conducto Radicular/farmacología , Hipoclorito de Sodio/farmacología , Bacteriocinas/farmacología , Porphyromonas gingivalis/efectos de los fármacos , Porphyromonas gingivalis/aislamiento & purificación , Streptococcus mutans/efectos de los fármacos , Streptococcus mutans/aislamiento & purificación , Prevotella/efectos de los fármacos , Prevotella/aislamiento & purificación
2.
Microb Genom ; 8(2)2022 02.
Artículo en Inglés | MEDLINE | ID: mdl-35113778

RESUMEN

Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are characterized by increasingly frequent acute pulmonary exacerbations that reduce life quality and length. Human airways are home to a rich polymicrobial environment, which includes members of the obligately anaerobic genus Prevotella. Despite their commonness, surprisingly little is known about the prevalence, role, genomic diversity and antimicrobial resistance (AMR) potential of Prevotella species and strains in healthy and diseased airways. Here, we used comparative genomics to develop a real-time PCR assay to permit rapid Prevotella species identification and quantification from cultures and clinical specimens. Assay specificity was validated across a panel of Prevotella and non-Prevotella species, followed by PCR screening of CF and COPD respiratory-derived cultures. Next, 35 PCR-positive isolates were subjected to whole-genome sequencing. Of eight identified Prevotella species, P. histicola, P. melaninogenica, P. nanceiensis, P. salivae and P. denticola overlapped between participant cohorts. Phylogenomic analysis revealed considerable interhost but limited intrahost diversity, suggesting patient-specific lineages in the lower airways, probably from oral cavity aspirations. Correlation of phenotypic AMR profiles with AMR genes identified excellent correlation between tetQ presence and decreased doxycycline susceptibility, and ermF presence and decreased azithromycin susceptibility and clindamycin resistance. AMR rates were higher in the CF isolates, reflecting greater antibiotic use in this cohort. All tested Prevotella isolates were tobramycin-resistant, providing a potential selection method to improve Prevotella culture retrieval rates. Our addition of 35 airway-derived Prevotella genomes to public databases will enhance ongoing efforts to unravel the role of this diverse and enigmatic genus in both diseased and healthy lungs.


Asunto(s)
Farmacorresistencia Bacteriana/genética , Genómica , Prevotella/genética , Prevotella/aislamiento & purificación , Enfermedad Pulmonar Obstructiva Crónica/microbiología , Antibacterianos/farmacología , Fibrosis Quística/microbiología , Humanos , Pulmón , Pruebas de Sensibilidad Microbiana , Prevotella/efectos de los fármacos , Esputo/microbiología
3.
Nutrients ; 13(11)2021 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-34836175

RESUMEN

A high-salt diet (HSD) is one of the key risk factors for hypertension and kidney injury. In this study, a HSD C57BL/6J mice model was established with 4% NaCl, and then different concentrations of Lactobacillus plantarum ZDY2013 were intragastrically administered for 2 weeks to alleviate HSD-induced renal injury. For the study, 16S rRNA gene sequencing, non-targeted metabonomics, real-time fluorescent quantitative PCR, and Masson's staining were used to investigate the mechanism of L. plantarum ZDY2013 in alleviating renal damage. Results showed that HSD caused intestinal inflammation and changed the intestinal permeability of mice, disrupted the balance of intestinal flora, and increased toxic metabolites (tetrahydrocorticosteron (THB), 3-methyhistidine (3-MH), creatinine, urea, and L-kynurenine), resulting in serious kidney damage. Interestingly, L. plantarum ZDY2013 contributed to reconstructing the intestinal flora of mice by increasing the level of Lactobacillus and Bifidobacterium and decreasing that of Prevotella and Bacteroides. Moreover, the reconstructed intestinal microbiota significantly changed the concentration of the metabolites of hosts through metabolic pathways, including TCA cycle, ABC transport, purine metabolism, and histidine metabolism. The content of uremic toxins such as L-kynurenine, creatinine, and urea in the serum of mice was found to be decreased by L. plantarum ZDY2013, which resulted in renal injury alleviation. Our data suggest that L. plantarum ZDY2013 can indeed improve chronic kidney injury by regulating intestinal flora, strengthening the intestinal barrier, limiting inflammatory response, and reducing uremic toxins.


Asunto(s)
Enfermedades Renales/tratamiento farmacológico , Riñón/lesiones , Lactobacillus plantarum , Probióticos/farmacología , Cloruro de Sodio Dietético/efectos adversos , Animales , Bifidobacterium/efectos de los fármacos , Dieta/efectos adversos , Microbioma Gastrointestinal/efectos de los fármacos , Inflamación/etiología , Inflamación/metabolismo , Intestinos/metabolismo , Enfermedades Renales/etiología , Enfermedades Renales/metabolismo , Lactobacillus/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Prevotella/efectos de los fármacos , ARN Ribosómico 16S/metabolismo
4.
Int J Mol Sci ; 22(19)2021 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-34638543

RESUMEN

Monensin is an ionophore for monovalent cations, which is frequently used to prevent ketosis and to enhance performance in dairy cows. Studies have shown the rumen bacteria Prevotella bryantii B14 being less affected by monensin. The present study aimed to reveal more information about the respective molecular mechanisms in P.bryantii, as there is still a lack of knowledge about defense mechanisms against monensin. Cell growth experiments applying increasing concentrations of monensin and incubations up to 72 h were done. Harvested cells were used for label-free quantitative proteomics, enzyme activity measurements, quantification of intracellular sodium and extracellular glucose concentrations and fluorescence microscopy. Our findings confirmed an active cell growth and fermentation activity of P.bryantii B14 despite monensin concentrations up to 60 µM. An elevated abundance and activity of the Na+-translocating NADH:quinone oxidoreductase counteracted sodium influx caused by monensin. Cell membranes and extracellular polysaccharides were highly influenced by monensin indicated by a reduced number of outer membrane proteins, an increased number of certain glucoside hydrolases and an elevated concentration of extracellular glucose. Thus, a reconstruction of extracellular polysaccharides in P.bryantii in response to monensin is proposed, which is expected to have a negative impact on the substrate binding capacities of this rumen bacterium.


Asunto(s)
Transporte Iónico/efectos de los fármacos , Monensina/farmacología , Polisacáridos Bacterianos/metabolismo , Prevotella/efectos de los fármacos , Ionóforos de Sodio/farmacología , Animales , Bovinos , Membrana Celular/metabolismo , Farmacorresistencia Bacteriana/genética , Farmacorresistencia Bacteriana/fisiología , Perfilación de la Expresión Génica , Transporte Iónico/fisiología , Consumo de Oxígeno/efectos de los fármacos , Prevotella/crecimiento & desarrollo , Quinona Reductasas/metabolismo , Rumen/microbiología , Sodio/metabolismo
5.
Front Immunol ; 12: 609644, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34017324

RESUMEN

Bacterial therapeutics are the emergent alternatives in treating autoimmune diseases such as Rheumatoid Arthritis [RA]. P. histicola MCI 001 is one such therapeutic bacterium that has been proven to treat autoimmune diseases such as RA and multiple sclerosis [MS] in animal models. The present study characterized P. histicola MCI 001 isolated from a human duodenal biopsy, and evaluated its impact on the gut microbial and metabolic profile in a longitudinal study using the collagen-induced arthritis model in HLA-DQ8.AEo transgenic mice. P. histicola MCI 001 though closely related to the type strain of P. histicola, DSM 19854, differed in utilizing glycerol. In culture, P. histicola MCI 001 produced vitamins such as biotin and folate, and was involved in digesting complex carbohydrates and production of acetate. Colonization study showed that duodenum was the predominant niche for the gavaged MCI 001. A longitudinal follow-up of gut microbial profile in arthritic mice treated with MCI 001 suggested that dysbiosis caused due to arthritis was partially restored to the profile of naïve mice after treatment. A taxon-level analysis suggested an expansion of intestinal genus Allobaculum in MCI001 treated arthritic mice. Eubiosis achieved post treatment with P. histicola MCI 001 was also reflected in the increased production of short-chain fatty acids [SCFAs]. Present study suggests that the treatment with P. histicola MCI 001 leads to an expansion of Allobaculum by increasing the availability of simple carbohydrates and acetate. Restoration of microbial profile and metabolites like butyrate induce immune and gut homeostasis.


Asunto(s)
Terapia Biológica/métodos , Butiratos/metabolismo , Prevotella/fisiología , Simbiosis , Adaptación Fisiológica , Animales , Artritis Reumatoide/diagnóstico , Artritis Reumatoide/etiología , Artritis Reumatoide/metabolismo , Artritis Reumatoide/terapia , Ácidos y Sales Biliares/farmacología , Modelos Animales de Enfermedad , Ácidos Grasos Volátiles/metabolismo , Jugo Gástrico , Microbioma Gastrointestinal , Humanos , Concentración de Iones de Hidrógeno , Ratones , Ratones Transgénicos , Prevotella/clasificación , Prevotella/efectos de los fármacos , Prevotella/genética
6.
J Biomed Mater Res B Appl Biomater ; 109(10): 1588-1600, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-33622023

RESUMEN

Peri-implant diseases are one of the main causes of dental implant failure. New strategies for dental implants manufacturing have been developed to prevent the accumulation of bacteria and related inflammatory reactions. The main aim of this work was to develop laser-treated titanium surfaces covered with silver that generate a electrical dipole to inhibit the oral bacteria accumulation. Two approaches were developed for that purpose. In one approach a pattern of different titanium dioxide thickness was produced on the titanium surface, using a Q-Switched Nd:YAG laser system operating at 1064 nm. The second approach was to incorporate silver particles on a laser textured titanium surface. The incorporation of the silver was performed by laser sintering and hot-pressing approaches. The anti-biofilm effect of the discs were tested against biofilms involving 14 different bacterial strains growth for 24 and 72 hr. The morphological aspects of the surfaces were evaluated by optical and field emission guns scanning electronical microscopy (FEGSEM) and therefore the wettability and roughness were also assessed. Physicochemical analyses revealed that the test surfaces were hydrophilic and moderately rough. The oxidized titanium surfaces showed no signs of antibacterial effects when compared to polished discs. However, the discs with silver revealed a decrease of accumulation of Porphyromonas gingivalis and Prevotella intermedia strains. Thus, the combination of Nd:YAG laser irradiation and hot-pressing was effective to produce silver-based patterns on titanium surfaces to inhibit the growth of pathogenic bacterial species. The laser parameters can be optimized to achieve different patterns, roughness, and thickness of the modified titanium layer regarding the type and region of the implant.


Asunto(s)
Antibacterianos/química , Nanopartículas del Metal/química , Plata/química , Titanio/química , Antibacterianos/farmacología , Biopelículas , Interacciones Hidrofóbicas e Hidrofílicas , Porphyromonas gingivalis/efectos de los fármacos , Prevotella/efectos de los fármacos , Plata/farmacología , Propiedades de Superficie , Titanio/metabolismo
7.
J Immunol Res ; 2020: 9607328, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33204736

RESUMEN

Th17-mediated mucosal inflammation is related to increased Prevotella bacterial abundance. The actual involvement of Prevotella in the development and accumulation of intestinal Th17 cells at a steady state, however, remains undefined. Herein, we investigated the role of Prevotella in inducing intestinal Th17 cells in mice. Mice were treated with a combination of broad-spectrum antibiotics (including ampicillin, neomycin sulfate, vancomycin hydrochloride, and metronidazole) in their drinking water for 4 weeks and then gavaged with Prevotella for 4 weeks. After inoculation, 16S rDNA sequencing was used to verify the colonization of Prevotella in the colon of mice. The IL-17A as well as IL-17A-expressing T cells was localized and quantified by an immunofluorescence assay (IFA) of colon sections. Th17 cells in the mesenteric lymph nodes of mice were counted by flow cytometry. Systemic immune response to Prevotella colonization was evaluated based on the serum levels of IL-6, TNF-α, IL-1ß, IL-17A, IL-10, IL-4, IFN-γ, and IL-2. Th17-polarizing cytokines (IL-6, TNF-α, IL-1ß, and IL-2) induced by Prevotella were evaluated by stimulation of bone marrow-derived dendritic cells (BMDCs). Results revealed that after inoculation, Prevotella successfully colonized the intestine of mice and induced the production and accumulation of colonic Th17 cells in the colon. Moreover, Prevotella elevated some of the Th17-related cytokines in the serum of mice. And Th17-polarizing cytokines (IL-6 and IL-1ß) produced by BMDCs were mediated mainly through the interaction between Prevotella and Toll-like receptor 2 (TLR2). In conclusion, our data suggest that Prevotella induces the production of Th17 cells in the colon of mice, thus highlighting the potential role of Prevotella in training the intestinal immune system.


Asunto(s)
Colon/inmunología , Colon/metabolismo , Microbioma Gastrointestinal/inmunología , Mucosa Intestinal/inmunología , Mucosa Intestinal/metabolismo , Prevotella/inmunología , Células Th17/inmunología , Células Th17/metabolismo , Animales , Antibacterianos/farmacología , Colon/microbiología , Citocinas/biosíntesis , Citocinas/sangre , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Microbioma Gastrointestinal/efectos de los fármacos , Regulación de la Expresión Génica , Inmunofenotipificación , Interleucina-17/genética , Interleucina-17/metabolismo , Activación de Linfocitos/efectos de los fármacos , Activación de Linfocitos/inmunología , Metagenoma , Metagenómica/métodos , Ratones , Ratones Transgénicos , Prevotella/efectos de los fármacos
8.
PLoS One ; 15(10): e0241338, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33125401

RESUMEN

BACKGROUND: The study was conducted to investigate the effects of metformin treatment on the human gut microbiome's taxonomic and functional profile in the Latvian population, and to evaluate the correlation of these changes with therapeutic efficacy and tolerance. METHODS: In this longitudinal observational study, stool samples for shotgun metagenomic sequencing-based analysis were collected in two cohorts. The first cohort included 35 healthy nondiabetic individuals (metformin dose 2x850mg/day) at three time-points during metformin administration. The second cohort was composed of 50 newly-diagnosed type 2 diabetes patients (metformin dose-determined by an endocrinologist) at two concordant times. Patients were defined as Responders if their HbA1c levels during three months of metformin therapy had decreased by ≥12.6 mmol/mol (1%), while in Non-responders HbA1c were decreased by <12.6 mmol/mol (1%). RESULTS: Metformin reduced the alpha diversity of microbiota in healthy controls (p = 0.02) but not in T2D patients. At the species level, reduction in the abundance of Clostridium bartlettii and Barnesiella intestinihominis, as well as an increase in the abundance of Parabacteroides distasonis and Oscillibacter unclassified overlapped between both study groups. A large number of group-specific changes in taxonomic and functional profiles was observed. We identified an increased abundance of Prevotella copri (FDR = 0.01) in the Non-Responders subgroup, and enrichment of Enterococcus faecium, Lactococcus lactis, Odoribacter, and Dialister at baseline in the Responders group. Various taxonomic units were associated with the observed incidence of side effects in both cohorts. CONCLUSIONS: Metformin effects are different in T2D patients and healthy individuals. Therapy induced changes in the composition of gut microbiome revealed possible mediators of observed short-term therapeutic effects. The baseline composition of the gut microbiome may influence metformin therapy efficacy and tolerance in T2D patients and could be used as a powerful prediction tool.


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/microbiología , Microbioma Gastrointestinal/fisiología , Metformina/uso terapéutico , Adulto , Bacteroidetes/efectos de los fármacos , Femenino , Humanos , Lactococcus lactis/efectos de los fármacos , Estudios Longitudinales , Masculino , Microbiota/efectos de los fármacos , Prevotella/efectos de los fármacos , Adulto Joven
9.
BMC Microbiol ; 20(1): 283, 2020 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-32928123

RESUMEN

BACKGROUND: The human colon is colonised by a dense microbial community whose species composition and metabolism are linked to health and disease. The main energy sources for colonic bacteria are dietary polysaccharides and oligosaccharides. These play a major role in modulating gut microbial composition and metabolism, which in turn can impact on health outcomes. RESULTS: We investigated the influence of wheat bran arabinoxylan oligosaccharides (AXOS) and maltodextrin supplements in modulating the composition of the colonic microbiota and metabolites in healthy adults over the age of 60. Male and female volunteers, (n = 21, mean BMI 25.2 ± 0.7 kg/m2) participated in the double-blind, cross over supplement study. Faecal samples were collected for analysis of microbiota, short chain fatty acids levels and calprotectin. Blood samples were collected to measure glucose, cholesterol and triglycerides levels. There was no change in these markers nor in calprotectin levels in response to the supplements. Both supplements were well-tolerated by the volunteers. Microbiota analysis across the whole volunteer cohort revealed a significant increase in the proportional abundance of faecal Bifidobacterium species (P ≤ 0.01) in response to AXOS, but not maltodextrin, supplementation. There was considerable inter-individual variation in the other bacterial taxa that responded, with a clear stratification of volunteers as either Prevotella-plus (n = 8; > 0.1% proportional abundance) or Prevotella-minus (n = 13; ≤0.1% proportional abundance) subjects founded on baseline sample profiles. There was a significant increase in the proportional abundance of both faecal Bifidobacterium (P ≤ 0.01) and Prevotella species (P ≤ 0.01) in Prevotella-plus volunteers during AXOS supplementation, while Prevotella and Bacteroides relative abundances showed an inverse relationship. Proportional abundance of 26 OTUs, including bifidobacteria and Anaerostipes hadrus, differed significantly between baseline samples of Prevotella-plus compared to Prevotella-minus individuals. CONCLUSIONS: The wheat bran AXOS supplementation was bifidogenic and resulted in changes in human gut microbiota composition that depended on the initial microbiota profile, specifically the presence or absence of Prevotella spp. as a major component of the microbiota. Our data therefore suggest that initial profiling of individuals through gut microbiota analysis should be considered important when contemplating nutritional interventions that rely on prebiotics. TRIAL REGISTRATION: Clinical trial registration number: NCT02693782 . Registered 29 February 2016 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02693782?term=NCT02693782&rank=1.


Asunto(s)
Fibras de la Dieta , Microbioma Gastrointestinal/fisiología , Oligosacáridos/farmacología , Prevotella/fisiología , Anciano , Suplementos Dietéticos , Método Doble Ciego , Ácidos Grasos Volátiles/metabolismo , Heces/química , Heces/microbiología , Femenino , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Complejo de Antígeno L1 de Leucocito/análisis , Lípidos/sangre , Masculino , Persona de Mediana Edad , Oligosacáridos/química , Polisacáridos/farmacología , Prebióticos , Prevotella/efectos de los fármacos , Xilanos
10.
Anaerobe ; 65: 102240, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32768494

RESUMEN

Penicillins, can be used in treatment of infections due to Prevotella species if they are susceptible to penicillin. Early and accurate preliminary detection of ß-lactamase-producing isolates is crucial for treatment of infection. The aim of this study was to determine ß-lactamase-producing Prevotella species by MALDI-TOF MS and screen them for the presence of cfxA gene, responsible for ß-lactamase production. A total of 500 clinically relevant Prevotella isolates, collected from 13 countries for the previous European antibiotic resistance surveillance study, were tested. Susceptibility testing was performed against ampicillin and ampicillin/sulbactam by Etest methodology. EUCAST guidelines were used for susceptibility interpretations; the isolates with MIC value ≤ 0.5 for ampicillin were considered susceptible and >2 resistant. All Prevotella isolates, were tested for detection of ß-lactamase activity by MALDI-TOF MS (Vitek® MS Research Use Only) system and the presence of the cfxA gene by PCR method. The susceptibility levels of the isolates to ampicillin/sulbactam and ampicillin were 99.6% and 43.4%, respectively. A total 59% of isolates presented ß-lactamase activity and 60.8% were cfxA gene positive. Both these tests were positive for isolates in the resistant category. Additionally, >95% of the isolates (n = 65) which ampicillin MIC values ranged from >0.5 µg/mL to 2 µg/ml displayed ß-lactamase activity. We also found that the MALDI-TOF MS-based ß-lactamase assay delivers results in 2 h. We found a high concordance between the MALDI-TOF MS ß-lactamase results in terms of cfxA ß-lactamase gene presence. MALDI-TOF MS may serve as a simple and efficient alternative method of the existing phenotypic and PCR-based methods.


Asunto(s)
Técnicas de Tipificación Bacteriana , Infecciones por Bacteroidaceae/microbiología , Prevotella/clasificación , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , beta-Lactamasas/biosíntesis , Antibacterianos/farmacología , Infecciones por Bacteroidaceae/diagnóstico , Farmacorresistencia Bacteriana , Humanos , Pruebas de Sensibilidad Microbiana , Prevotella/efectos de los fármacos , Prevotella/metabolismo , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , beta-Lactamasas/genética
11.
Anaerobe ; 65: 102249, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32768495

RESUMEN

The association of Prevotella bivia (P. bivia), a Gram negative obligate anaerobic bacillus with brain abscess has been rarely reported. We hereby, report a case of brain abscess in a 50-year-old man, who suffered a head trauma followed by decompression surgery 10 months ago. Aspirated pus sample grew Methicillin resistant Staphylococcus aureus (MRSA) and P. bivia sensitive to metronidazole. The patient recovered well after a brain abscess evacuation surgery and post-operative metronidazole therapy, confirming the pathogenic role of P. bivia in this case.


Asunto(s)
Infecciones por Bacteroidaceae/diagnóstico , Infecciones por Bacteroidaceae/microbiología , Absceso Encefálico/diagnóstico , Absceso Encefálico/microbiología , Prevotella , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Infecciones por Bacteroidaceae/terapia , Absceso Encefálico/terapia , Terapia Combinada , Humanos , India , Masculino , Metronidazol/farmacología , Metronidazol/uso terapéutico , Persona de Mediana Edad , Complicaciones Posoperatorias , Prevotella/clasificación , Prevotella/efectos de los fármacos , Resultado del Tratamiento
12.
Mikrobiyol Bul ; 54(2): 246-256, 2020 Apr.
Artículo en Turco | MEDLINE | ID: mdl-32723280

RESUMEN

Prevotella species, being members of the human microbiota, are obligate anaerobic gram-negative bacteria. These organisms may cause opportunistic infections, including specific oral infections, local or systemic infections. A significant increase of resistance to some antimicrobials has been detected among Prevotella species. The frequency of resistance vary among isolates from different infection sources and between geographic locations. The knowledge about the antimicrobial susceptibility patterns of different Prevotella species is limited in Turkey. Providing the antimicrobial susceptibility data of these bacteria is very important for effective empirical treatment. In this study, we aimed to determine susceptibility data for 12 antimicrobial agents against Prevotella strains originating from human infections, collected in two centers in Turkey. A total of 118 Prevotella strains, isolated from different clinical samples in Marmara University Faculty of Medicine Medical Microbiology and Istanbul University Faculty of Dentistry Oral Microbiology Laboratories between January 2014-December 2017, were tested. Organisms were identified by using MALDI-TOF MS and by 16S rRNA gene sequencing. Minimal inhibitor concentrations of ampicillin, ampicillin-sulbactam, piperacillin-tazobactam, cefoxitin, meropenem, imipenem, clindamycin, tetracycline, tigecycline, moxifloxacin and metronidazole were determined using gradiyent test methodology (E-test; bioMerieux, France) and the European Committee on Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute and Food and Drug Administration guidelines were used for interpretation. Thirteen different Prevotella species were identified, Prevotella bivia and Prevotella nigrescens were the most prevalent species (n= 21) followed by Prevotella buccae (n= 19). All Prevotella strains were susceptible to piperacillin-tazobactam, cefoxitin, meropenem, imipenem and tigecycline. A total of 2 (1.7%) isolates were resistant to metronidazole and 1 (0.8%) isolate was intermediately resistant to ampicillin/sulbactam. The frequency of resistant isolates against ampicillin, clindamycin, tetracycline and moxifloxacin were 57.6%, 36.4%, 18% and 16.3%, respectively. In conclusion, piperacillin/tazobactam, cefoxitin, and tigecycline displayed high in vitro activity against Prevotella spp. and they all remained good candidates for empiric therapy. Imipenem and meropenem were also found to be very active, but the usage of carbapenems should be reserved for serious mixed infections, potentially accompanied by other resistant organisms. Intermediate resistance to ampicillinsulbactam and the resistance against metronidazole emphasized the need of periodic monitoring of their susceptibility patterns. The high rates of non-susceptibility to ampicillin, clindamycin, tetracycline and moxifloxacin indicated that these antimicrobials should not be used for treatment of infections without prior antimicrobial susceptibility testing.


Asunto(s)
Bacterias Anaerobias , Prevotella , Antibacterianos/farmacología , Infecciones por Bacteroidaceae/microbiología , Humanos , Pruebas de Sensibilidad Microbiana , Prevotella/efectos de los fármacos , Prevotella/genética , ARN Ribosómico 16S/genética , Turquía
13.
J Microbiol ; 58(7): 588-597, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32424577

RESUMEN

Our study demonstrated that sleep deprivation resulted in homeostasis disorder of colon. Our study goes deeper into the positive effects of melatonin on small intestinal microbiota disorder caused by sleep deprivation. We successfully established a multiplatform 72 h sleep deprivation mouse model with or without melatonin supplementation, and analyzed the change of small intestinal microbiota using high-throughput sequencing of the 16S rRNA. We found melatonin supplementation suppressed the decrease of plasma melatonin level in sleep deprivation mice. Meanwhile, melatonin supplementation improved significantly the reduction in OTU numbers and the diversity and richness of jejunal microbiota and the abundance of Bacteroidaeae and Prevotellaceae, as well as an increase in the Firmicutes-to-Bacteroidetes ratio and the content of Moraxellaceae and Aeromonadaceae in the jejunum of sleep deprived-mice. Moreover, melatonin supplementation reversed the change of metabolic pathway in sleep deprived-mice, including metabolism, signal transduction mechanisms and transcription etc, which were related to intestinal health. Furthermore, melatonin supplementation inverted the sleep deprivation-induced a decline of anti-inflammatory cytokines (IL-22) and an increase of the ROS and proinflammatory cytokines (IL-17) in jejunum. These findings suggested that melatonin, similar to a probiotics agent, can reverse sleep deprivation-induced small intestinal microbiota disorder by suppressing oxidative stress and inflammation response.


Asunto(s)
Antioxidantes/farmacología , Disbiosis/tratamiento farmacológico , Microbioma Gastrointestinal/efectos de los fármacos , Yeyuno/microbiología , Melatonina/farmacología , Privación de Sueño/microbiología , Aeromonadaceae/efectos de los fármacos , Aeromonadaceae/aislamiento & purificación , Animales , Bacteroidaceae/efectos de los fármacos , Bacteroidaceae/aislamiento & purificación , Firmicutes/efectos de los fármacos , Firmicutes/aislamiento & purificación , Inflamación , Interleucina-17/análisis , Interleucinas/análisis , Masculino , Ratones , Ratones Endogámicos ICR , Moraxellaceae/efectos de los fármacos , Moraxellaceae/aislamiento & purificación , Estrés Oxidativo/efectos de los fármacos , Prevotella/efectos de los fármacos , Prevotella/aislamiento & purificación , ARN Ribosómico 16S/genética , Transducción de Señal/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Transcripción Genética/genética , Interleucina-22
14.
J Nutr Biochem ; 82: 108396, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32388163

RESUMEN

Colorectal cancer (CRC) is one of the major malignancies in humans. This study was designed to evaluate the effects of fucoidan on gut flora and tumor prevention in 1,2-dimethylhydrazine-induced colorectal carcinogenesis in rats. We found that dietary fucoidan treatment decreased the tumor incidence and mean tumor weight and increased cell apoptosis. Fucoidan treatment decreased the expression of ß-catenin C-Myc, CyclinD1 and Survivin, while the Hippo pathway was activated with increased phosphorylation levels of mammalian sterile 20-like kinase 1 and 2, large tumor suppressor 1 and 2, and Yes-associated protein. Compared with the model group, the levels of interleukin (IL)-17 and IL-23 were decreased, but the levels of interferon-γ, IL-4 and IL-10 were increased, in the fucoidan group. Fucoidan treatment increased natural killer cells in peripheral blood and the proportion of CD4+ T cells. Immunofluorescence detection of colorectal tumor tissues showed decreased expression of Foxp3 and up-regulated expression of CD68 in the fucoidan group. Moreover, fucoidan treatment decreased the levels of diamine oxidase and lipopolysaccharides and up-regulated the levels of tight junction proteins. 16S rDNA high-throughput sequencing revealed that fucoidan treatment decreased the abundance of Prevotella and increased the abundance of Alloprevotella. Fucoidan increased the levels of butyric acid and valeric acid compared to the model group. This study provides experimental evidence that dietary fucoidan may prevent colorectal tumorigenesis by regulating gut microecology and body immunity. Meanwhile, fucoidan activated the Hippo pathway and down-regulated the ß-catenin pathway to induce tumor cell apoptosis and suppress tumor growth.


Asunto(s)
1,2-Dimetilhidrazina/efectos adversos , Antineoplásicos/farmacología , Neoplasias Colorrectales/prevención & control , Microbioma Gastrointestinal/efectos de los fármacos , Polisacáridos/farmacología , Animales , Antineoplásicos/administración & dosificación , Apoptosis/efectos de los fármacos , Bacteroidetes/efectos de los fármacos , Carcinogénesis , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/metabolismo , Regulación hacia Abajo , Humanos , Mucosa Intestinal/metabolismo , Masculino , Polisacáridos/administración & dosificación , Prevotella/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , Survivin/metabolismo , Regulación hacia Arriba , Vía de Señalización Wnt
15.
BMJ Case Rep ; 13(1)2020 Jan 08.
Artículo en Inglés | MEDLINE | ID: mdl-31919070

RESUMEN

A 76-year-old man presented with neck swelling associated with pain and fever. On examination, there was a submental neck swelling. His initial CT scan showed multiloculated abscess centred in the left submandibular gland. He remained febrile despite on intravenous ceftriaxone and metronidazole. A repeat CT scan revealed significant worsening with multiple pockets of fluids with gas locules in the deep neck spaces. He subsequently underwent neck exploration and drainage of neck abscess. Extensive necrotic tissue was found intraoperatively and thick pus was drained from the bilateral parapharyngeal, submental spaces and anterior mediastium. Pus culture profusely grew of Eggerthella species. Patient recovered well following further intravenous antibiotic therapy. Diabetes mellitus and odontogenic infections are the common risk factors in deep neck infections. Our patient is however non-diabetic and edentulous. Current case is presented to serve as a rare case of neck abscess with unusual cause in a non-diabetic patient.


Asunto(s)
Absceso/microbiología , Absceso/terapia , Actinobacteria/efectos de los fármacos , Cuello/microbiología , Cuello/cirugía , Prevotella/efectos de los fármacos , Absceso/diagnóstico por imagen , Anciano , Antibacterianos/uso terapéutico , Terapia Combinada , Diagnóstico Diferencial , Humanos , Masculino , Cuello/diagnóstico por imagen , Tomografía Computarizada por Rayos X
16.
Int J Food Sci Nutr ; 71(5): 563-571, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31910700

RESUMEN

Dextrans are homopolysaccharides of D-glucose units produced by lactic acid bacteria. They have several technological applications and potential utilisation in positively modulating gut microbiota is attracting increasing attention. Whereas the prebiotic activity of low polymerisation degree (DP) dextrans has been established, high DP dextrans still deserve deeper investigation. In the present study, a long linear chain dextran produced by Weissella cibaria was compared to inulin with regards to the growth of specific health-related taxa and to the production of organic acids in pH-controlled batch cultures of intestinal microbiota. qPCR quantification of Lactobacillus, Bifidobacterium, Prevotella, Bacteroides fragilis, and Faecalibacterium prausnitzii revealed differences in their relative abundance, depending on the carbon source, that reflected the pattern of fermentation products determined by HPLC. Dextran mainly enhanced the relative amount of Prevotella and Bacteroides, consistently with a favourable acetate-propionate ratio suggesting a promising utilisation as functional ingredient in the food industry.


Asunto(s)
Bacterias/efectos de los fármacos , Dextranos/farmacología , Microbioma Gastrointestinal , Prebióticos , Weissella/metabolismo , Ácido Acético/metabolismo , Bacterias/crecimiento & desarrollo , Bacterias/metabolismo , Bacteroides fragilis/efectos de los fármacos , Bacteroides fragilis/crecimiento & desarrollo , Bacteroides fragilis/metabolismo , Cromatografía Líquida de Alta Presión , Dextranos/biosíntesis , Fermentación , Alimentos Funcionales , Humanos , Inulina , Reacción en Cadena de la Polimerasa , Polimerizacion , Prevotella/efectos de los fármacos , Prevotella/crecimiento & desarrollo , Prevotella/metabolismo , Propionatos/metabolismo
17.
Int J Biol Macromol ; 149: 732-740, 2020 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-31987946

RESUMEN

The polysaccharides and phenylethanoid glycosides from Cistanche deserticola have been demonstrated with various health benefits, however the interactive effect between these two kinds of compounds in vivo are not in detail known. The objective of this study was to investigate the synergistic actions of cistanche polysaccharides with phenylethanoid glycoside and the effects of polysaccharides on gut microbiota. Sprague-Dawley rats were fed with different kinds of cistanche polysaccharides for 20 days, on the last day, all rats were administered the echinacoside at 100 mg/kg. The results were compared mainly on the difference of pharmacokinetic parameters, gut microbiota composition, and short chain fatty acids contents. The results indicated that all the cistanche polysaccharides, including crude polysaccharide, high molecular weight polysaccharide and low molecular weight polysaccharide, could regulate the gut microbiota diversity, increase beneficial bacteria and particularly enhance the growth of Prevotella spp. as well as improve the production of short chain fatty acids and the absorption of echinacoside. By exploring the synergistic actions of polysaccharides with small molecules, these findings suggest that cistanche polysaccharides, particularly low molecular weight polysaccharides, could be used as a gut microbiota manipulator for health promotion.


Asunto(s)
Cistanche/química , Microbioma Gastrointestinal/efectos de los fármacos , Glicósidos/metabolismo , Fenómenos Físicos , Extractos Vegetales/farmacología , Polisacáridos/farmacología , Animales , Ácidos Grasos Volátiles/metabolismo , Masculino , Peso Molecular , Extractos Vegetales/química , Polisacáridos/química , Prevotella/efectos de los fármacos , Prevotella/crecimiento & desarrollo , ARN Ribosómico 16S , Ratas , Ratas Sprague-Dawley
18.
Mater Sci Eng C Mater Biol Appl ; 106: 110295, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31753350

RESUMEN

Hexagonal nanocrystalline powders of the non-doped Ca10(PO4)6(OH)2 as well as activated with Ag+ and Eu3+ ions were synthesized by using different wet chemistry methods. Moreover, the obtained hydroxyapatite was loaded with Ag0, as well as nitroimidazole antimicrobials: metronidazole and tinidazole. The structural properties of the products were analyzed by X-ray diffraction (XRD), scanning (SEM) and transmission (TEM) electron microscopy as well as infrared (IR) and Raman spectroscopy. The photoluminescence properties of the Eu3+ and Ag+ co-doped Ca10(PO4)6(OH)2 were characterized via the PL emission, excitation spectra and the luminescence decay curve. The antimicrobial activity of the obtained materials against Prevotella bivia and Parabacteroides distasonis was studied. The cytotoxicity assessment was carried out on the human osteosarcoma cell line (U2OS) as well as human red blood cells (RBC). The choice of the in vitro model was based on the fact that U2OS is a cancer cell line derived from bone tissue which is rich in apatites that play a pivotal role in the extracellular matrix formation. RBCs are the most abundant blood cells and they are used as a cell model in the study of biocompatibility of new prepared biocompounds with potential medical applications. The obtained multifunctional materials do not exhibit the haemolytic activity, therefore, they could be used as a promising antimicrobial agent and for anaerobic bacteria.


Asunto(s)
Bacteroidetes/efectos de los fármacos , Materiales Biocompatibles/farmacología , Hidroxiapatitas/química , Nanocompuestos/química , Prevotella/efectos de los fármacos , Adsorción , Animales , Materiales Biocompatibles/síntesis química , Materiales Biocompatibles/química , Sedimentación Sanguínea/efectos de los fármacos , Bovinos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Europio/química , Hemólisis/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Muramidasa/química , Nanocompuestos/toxicidad , Albúmina Sérica Bovina/química , Plata/química
19.
J Dairy Sci ; 103(2): 1431-1447, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31785878

RESUMEN

This study was conducted to examine the effects of clay (CL) and Saccharomyces cerevisiae fermentation product (SCFP) on the ruminal bacterial community of Holstein dairy cows challenged with aflatoxin B1 (AFB1). A second objective was to examine correlations between bacterial abundance and performance measures. Eight lactating dairy cows stratified by milk yield and parity were randomly assigned to 4 treatments in a 4 × 4 Latin square design with 2 replicate squares, four 33-d periods, and a 5-d washout between periods. The treatments included (1) control (basal diet, no additive); (2) T (control + 63.4 µg/kg AFB1, oral dose); (3) CL (T + 200 g/head per day of sodium bentonite clay, top-dress); and (4) CL+SCFP [CL + 19 g/head per day Diamond V NutriTek (Diamond V Inc., Cedar Rapids, IA) + 16 g/head per day MetaShield (Diamond V Inc.), top-dress]. Cows were adapted to diets containing no AFB1 from d 1 to 25 (predosing period). From d 26 to 30 (dosing period), AFB1 was orally dosed and then withdrawn for d 31 to 33 (withdrawal period). During the predosing period, compared with the control, feeding CL and CL+SCFP increased the relative abundance of the most dominant phylum, Bacteroidetes (55.1 and 55.8 vs. 50.6%, respectively), and feeding CL+SCFP increased Prevotella abundance (43.3 and 43.6 vs. 40.0%, respectively). During the dosing period, feeding AFB1 did not affect the ruminal bacterial community, but the relative abundance of Fibrobacteraceae increased with CL+SCFP compared with T (1.45 vs. 0.97%); Fibrobacter abundance also tended to increase with CL+SCFP compared with T and control, respectively (1.45 vs. 0.97 and 1.05%, respectively). Feeding AFB1 with or without CL or CL+SCFP did not affect ruminal pH or concentrations of NH3-N, total volatile fatty acids, or individual volatile fatty acids. Milk yield and milk component yields were positively correlated with the relative abundance of unclassified Succinivibrionaceae, unclassified YS2, or Coprococcus. Feed efficiency was positively correlated (r ≥ 0.30) with the relative abundance of unclassified YS2, Coprococcus, or Treponema. Feeding aflatoxin at 63 µg/kg, a common contamination level on farms, did not affect the abundance of dominant bacteria or rumen fermentation. When aflatoxin was fed, CL+SCFP increased the abundance of Fibrobacter, a major fibrolytic bacteria genus. Milk yield and DMI were positively correlated with abundance of Succinivibrionaceae and Coprococcus. Feed efficiency was positively correlated with abundance of Coprococcus, Treponema, and YS2. Future studies should speciate culture and determine the functions of the bacteria to elucidate their roles in the rumen and potential contribution to increasing the performance of dairy cows.


Asunto(s)
Aflatoxina B1/efectos adversos , Bentonita/farmacología , Bovinos/microbiología , Microbioma Gastrointestinal/efectos de los fármacos , Leche/metabolismo , Saccharomyces cerevisiae/química , Secuestrantes/farmacología , Animales , Arcilla , Dieta/veterinaria , Ácidos Grasos Volátiles/metabolismo , Femenino , Fermentación , Lactancia , Paridad , Embarazo , Prevotella/efectos de los fármacos , Prevotella/crecimiento & desarrollo , Distribución Aleatoria
20.
Cell Host Microbe ; 26(5): 691-701.e5, 2019 11 13.
Artículo en Inglés | MEDLINE | ID: mdl-31726031

RESUMEN

Understanding the role of the microbiota components in either preventing or favoring enteric infections is critical. Here, we report the discovery of a Listeria bacteriocin, Lmo2776, which limits Listeria intestinal colonization. Oral infection of conventional mice with a Δlmo2776 mutant leads to a thinner intestinal mucus layer and higher Listeria loads both in the intestinal content and deeper tissues compared to WT Listeria. This latter difference is microbiota dependent, as it is not observed in germ-free mice. Strikingly, it is phenocopied by pre-colonization of germ-free mice before Listeria infection with Prevotella copri, an abundant gut-commensal bacteria, but not with the other commensals tested. We further show that Lmo2776 targets P. copri and reduces its abundance. Together, these data unveil a role for P.copri in exacerbating intestinal infection, highlighting that pathogens such as Listeria may selectively deplete microbiota bacterial species to avoid excessive inflammation.


Asunto(s)
Antibacterianos/farmacología , Bacteriocinas/farmacología , Microbioma Gastrointestinal/efectos de los fármacos , Listeria monocytogenes/metabolismo , Listeriosis/prevención & control , Prevotella/crecimiento & desarrollo , Animales , Femenino , Microbioma Gastrointestinal/genética , Microbioma Gastrointestinal/fisiología , Vida Libre de Gérmenes , Humanos , Inflamación/prevención & control , Listeriosis/microbiología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Prevotella/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...